Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach
CM Clase et al, Ann Int Med, May 22, 2020
CM Clase et al, Ann Int Med, May 22, 2020
Pooling nasopharyngeal swab specimens to increase testing capacity for SARS-CoV-2
C Anderson et al, BIORXIV, May 22, 2020
C Anderson et al, BIORXIV, May 22, 2020
Improved measurement of racial/ethnic disparities in COVID-19 mortality in the United States
JR Goldstein et al, MEDRXIV, May 23, 2020
JR Goldstein et al, MEDRXIV, May 23, 2020
A score-based risk model for predicting severe COVID-19 infection as a key component of lockdown exit strategy
N Dagan et al, MEDRXIV, May 23, 2020
N Dagan et al, MEDRXIV, May 23, 2020
Remdesivir for the Treatment of Covid-19 — Preliminary Report
JH Beigel et al, NEJM, May 22, 2020
JH Beigel et al, NEJM, May 22, 2020
Preliminary results from the 1059 patients (538 assigned to remdesivir and 521 to placebo) with data available after randomization indicated that those who received remdesivir had a median recovery time of 11 days, as compared with 15 days in those who received placebo (rate ratio for recovery, 1.32; 95% CI, 1.12 to 1.55; P<0.001).
.png)
No hay comentarios:
Publicar un comentario